Suchergebnisse - (Subject:"Tocilizumab")

PubPharm (320)

1

Optimal time of starting tocilizumab in acute phase of adult-onset Still's disease and comparison of its efficacy with that of methotrexate : a case series and a review of the literature

enthalten in: Clinical rheumatology | 2024

von Suzuki, S. | Kataoka, Y. | Otani, T. | +4

2

Comparison of the efficacy and safety of tocilizumab, sarilumab, and olokizumab in patients with active rheumatoid arthritis : a network meta-analysis of randomized controlled trials

enthalten in: Zeitschrift fur Rheumatologie | 2024

von Ho Lee, Y. | Gyu Song, G.

3

Retention, safety and efficacy of off-label conventional treatments and biologics for chronic calcium pyrophosphate crystal inflammatory arthritis

enthalten in: Rheumatology (Oxford, England) | 2024

von Damart, J. | Filippou, G. | Andrès, M. | +15

4

Comparing tocilizumab biosimilar BAT1806/BIIB800 with reference tocilizumab in patients with moderate-to-severe rheumatoid arthritis with an inadequate response to methotrexate : a phase 3, randomised, multicentre, double-blind, active-controlled clinical trial

enthalten in: The Lancet. Rheumatology | 2024

von Leng, X. | Leszczyński, P. | Jeka, S. | +13

ErratumIn: Lancet Rheumatol. 2024 Feb 5;:. - PMID 38330989

5

The Meteoritics Trial : efficacy of methotrexate after remission-induction with tocilizumab and glucocorticoids in giant cell arteritis-study protocol for a randomized, double-blind, placebo-controlled, parallel-group phase II study

enthalten in: Trials | 2024

von Kreis, L. | Dejaco, C. | Schmidt, W. | +3

6

An MMP-2 Responsive Nanotheranostic Probe Enabled Synergistic Therapy of Rheumatoid Arthritis and MR/CT Assessment of Therapeutic Response In Situ

enthalten in: Advanced healthcare materials | 2023

von Chen, X. | Dai, D. | Ma, J. | +3

7

Certolizumab pegol, abatacept, tocilizumab or active conventional treatment in early rheumatoid arthritis : 48-week clinical and radiographic results of the investigator-initiated randomised controlled NORD-STAR trial

enthalten in: Annals of the rheumatic diseases | 2023

von Østergaard, M. | van Vollenhoven, R. | Rudin, A. | +96

8

Incident psoriasis under treatment with tumor necrosis factor-α inhibitors in juvenile idiopathic arthritis patients-analysis of the BiKeR registry

enthalten in: Rheumatology international | 2023

von Zimmer, A. | Klein, A. | Kuemmerle-Deschner, J. | +8

9

Compared efficacy of rituximab, abatacept, and tocilizumab in patients with rheumatoid arthritis refractory to methotrexate or TNF inhibitors agents : a systematic review and network meta-analysis

enthalten in: Advances in rheumatology (London, England) | 2023

von Pugliesi, A. | de Oliveira, A. | Oliveira, A. | +6

10

Feasibility of methotrexate discontinuation following tocilizumab and methotrexate combination therapy in patients with long-standing and advanced rheumatoid arthritis : a 3-year observational cohort study

enthalten in: Fukushima journal of medical science | 2023

von Miyata, M. | Hirabayashi, Y. | Munakata, Y. | +43

RetractionIn: Fukushima J Med Sci. 2024 Jan 27;70(1):55. - PMID 38267028

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[32]